Skip to Main Content

Paper Details

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Blood Adv
5
2023
AML, Beat AML, Cancer, Children, Children's Cancer, DNMT3A, DNTM3A, FLT3, FLT3-ITD, FLT3-ITD mutations, IDH, IDH mutations, IDH1, IDH2, IDHWT, IDHmut, IDHmut AML, IDHmut/NPM1mut AML, ITD, NPM1, NPM1 mutation, NPM1WT, NPM1mut, NPM1mut AML, Patients, acute myeloid leukemia, adult, internal tandem duplication, isocitrate, isocitrate dehydrogenase, isocitrate dehydrogenase (IDH) genes, patients, pediatric AML
Author NameAffiliation
Todd A Alonzo
Todd A AlonzoUniversity of Southern California Keck School of Medicine
Todd A Alonzo
Todd A AlonzoUniversity of Southern California Keck School of Medicine
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center
Jerald P RadichClinical Research Division, Fred Hutchinson Cancer Research Center
Jerald P RadichUniversity of Washington
Martin S TallmanMemorial Sloan Kettering Cancer Center
Richard AplencDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Richard AplencDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Edward A KolbNemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children
Derek L StirewaltClinical Research Division, Fred Hutchinson Cancer Research Center
Derek L StirewaltUniversity of Washington
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
  • 1 - 16

Datasets

Release 1.2